行 华福证券 纺织服饰 2025 年 05 月 18 日 业 研 究 行 业 纺织服饰 户外专题（二）：从专业到破圈，解析伯希和高 投资要点： 户外专题（二）：从专业到破圈，解析伯希和高性能户外增长密码 定 期 报 告 伯希和以"科技堆料"构建差异化优势，依托 PT-China 平台自主 研发 STORM BREATH 防水透湿等核心技术，并引入全球顶尖供应链 资源，形成"自主+外采"双轨技术体系。产品矩阵覆盖四大梯度系列 （巅峰、专业性能、山系列、经典系列），2024 年 SPU 达 572 个。渠 道策略上，线上 DTC 为核心（2024 年营收占比 77%），线下 DTC 通 过联营模式快速扩张，三年收入 CAGR 达 383%，一二线城市门店占 比提升至 62%，实现高效市场渗透。 行情数据 本周家电板块涨跌幅+0.3%，其中白电/黑电/小家电/厨电板块涨跌 幅分别+0.4%/-2.9%/+1.0%/+0.6%。原材料价格方面，LME 铜、LME 铝环比上周分别+1.32%、+4.95%。 本周纺织服装板块涨跌幅+1.01%，其中纺织制造涨跌幅+0.94%， 服装家纺涨跌幅+0.60%。本周 328 ...

Investment Rating - The report maintains an "Outperform" rating for the defense and military industry [4]. Core Insights - The core viewpoint emphasizes that domestic trade and military trade continue to drive demand in the industry [10][48]. Summary by Sections Industry Overview - The "New Era of China's National Security" white paper was released on May 12, outlining China's strategic focus on national security and its interaction with global stability [48]. - Recent defense sales agreements were made with Saudi Arabia, Qatar, and the UAE, totaling approximately $4.3 billion, indicating strong international demand for military equipment [49][50][51]. Market Performance - The military industry index (801740) decreased by 1.18% from May 12 to May 16, underperforming compared to the Shanghai and Shenzhen 300 index, which increased by 1.12% [19]. - The military index has increased by 0.68% since 2025, while the Shanghai and Shenzhen 300 index has decreased by 1.16%, showing relative strength in the long term [21]. Investment Opportunities - The report identifies three main investment lines: domestic trade, foreign trade, and self-sufficiency [54]. - Domestic Trade: Companies such as Tianqin Equipment, Gaode Infrared, and others are highlighted [54]. - Foreign Trade: Companies like Guangdong Hongda and Aerospace Rainbow are recommended [55]. - Self-Sufficiency: Companies involved in commercial engines and nuclear fusion are noted [56]. Financial Insights - As of May 16, the military industry index has a TTM price-to-earnings ratio of 65.05, indicating a high valuation but potential for recovery in demand by 2025 [53][38]. - Passive fund inflows into military ETFs have increased, suggesting a positive outlook for the sector [32].

Investment Rating - The report maintains an "Outperform" rating for the pharmaceutical industry [6]. Core Insights - The report emphasizes the significant progress in stem cell therapy across multiple indications, suggesting a focus on companies like Jiuzhitang and Zhongyuan Qihe [3][5]. - The investment strategy is centered around three main themes: innovation, recovery, and policy support, with a strong emphasis on innovative drugs as the most clear long-term trend in the pharmaceutical sector [5]. Summary by Sections 1. Investment Focus on Pharmaceutical Combinations - The recommended investment combination outperformed the pharmaceutical index by 2.8 percentage points and the broader market by 3.1 percentage points last week [12]. 2. Stem Cell Therapy: Policy and Progress - China's regenerative medicine has reached a world-leading level, with clear industry policies marking a golden development period for stem cell therapy [17]. - Multiple indications are seeing critical advancements, with expectations for key data releases this year [17]. - The first domestically approved stem cell therapy was launched in January 2025, marking a historic turning point for the industry [6][17]. 3. Weekly Market Review and Hotspot Tracking (May 12-16, 2025) - The CITIC Pharmaceutical Index rose by 1.4%, outperforming the CSI 300 Index by 0.3 percentage points, ranking 10th among CITIC's primary industry classifications [61]. - The pharmaceutical sub-sectors showed positive performance, with chemical raw materials up by 2.79% and traditional Chinese medicine up by 2.01% [64].

Investment Rating - The industry rating is "Outperform the Market" [7] Core Insights - Huawei's nova 14 series and Harmony OS computer product launch event is scheduled for May 19, 2025, marking it as one of the most significant events for Huawei in 2025 [3] - Apple's first foldable iPhone is expected to be released in the fall of 2026, alongside the iPhone 18 Pro series, with a projected global shipment of 3.8 million foldable smartphones in Q4 2024, a year-on-year decline of 18% [4] - Huawei holds a 31.2% market share in the foldable smartphone segment, while Samsung's market share has decreased to 26.7% [4] Summary by Sections Product Launches - Huawei's upcoming launch includes the nova 14 series and a new Harmony OS computer, potentially the first foldable PC from Huawei [3] Market Trends - The foldable smartphone market is experiencing a decline, with a significant drop in shipments, but Apple's entry is expected to revitalize the market due to its strong brand and integration capabilities [4] Investment Opportunities - Suggested areas for investment include 3D printing applications (e.g., Huazhu High-Tech, Plittech), automated assembly equipment (e.g., Bozhong Precision, Kuaike Intelligent), and automated testing equipment (e.g., Oatmeal Technology, Jepter) [5]

Investment Rating - The report maintains a "Buy" rating for the company, indicating an expected relative price increase of over 20% compared to the market benchmark within the next six months [5][22]. Core Insights - The company has demonstrated impressive performance with a revenue of 3.56 billion yuan in 2024, reflecting a year-on-year growth of 76.3%, and a net profit of 1.43 billion yuan, up 122% year-on-year [2][5]. - The sales expense ratio has improved, decreasing by 5.9 percentage points to 39.7% in 2024, while the net profit margin increased by 8.27 percentage points to 40.2% [2][3]. - The innovative pipeline is progressing steadily, with multiple clinical trials for the drug Vomeletin ongoing, targeting various indications [4][5]. Financial Performance - In Q4 2024, the company achieved a revenue of 1.02 billion yuan, a 52.8% increase year-on-year, and a net profit of 370 million yuan, up 57% year-on-year [2]. - For Q1 2025, the company reported a revenue of 1.1 billion yuan, a 47.9% increase year-on-year, and a net profit of 410 million yuan, reflecting a 34.1% growth [3]. - The projected net profits for 2025, 2026, and 2027 are estimated at 1.7 billion yuan, 2.03 billion yuan, and 2.49 billion yuan, respectively, indicating a strong growth trajectory [5]. Cost Management - The company has effectively optimized its cost structure, with a decrease in the management expense ratio to 4.6% in 2024, down 1.9 percentage points year-on-year [2]. - The research and development expense ratio also saw a decline to 8.8%, down 6.7 percentage points year-on-year, indicating efficient allocation of resources [2]. Market Position and Growth Potential - The company is in a rapid growth phase with Vomeletin's market expansion and the introduction of new products, highlighting its long-term growth potential [5]. - The introduction of the KRASG12C inhibitor, Goretinib, is expected to enhance the company's product offerings and market presence [4][5].

Investment Rating - The report maintains an "Outperform" rating for the industry [6] Core Insights - The RE100 organization has unconditionally recognized China's green certificate, marking a significant step in the internationalization of green certificates, which will enhance the competitiveness of exports and support the development of green supply chain enterprises [3][18] - The release of the 136 document by Guangdong and Shandong provinces is expected to accelerate the marketization process of the renewable energy industry, shifting companies from reliance on policy subsidies to market competitiveness [4][24] - The recent urban renewal initiative aims to accelerate the renovation of urban infrastructure, including gas, water, and waste management systems, which is projected to enhance operational capabilities of existing waste-to-energy and waste treatment projects [35][39] Summary by Sections Market Review - From May 12 to May 16, the environmental, gas, and electricity sectors saw increases of 0.58%, 0.54%, and 0.09% respectively, while the water sector decreased by 0.43%, against a backdrop of a 1.12% rise in the CSI 300 index [12][18] Industry Dynamics - The green certificate market has seen significant growth, with a total of 5.617 billion certificates issued by the end of March 2025, and a transaction volume of 753 million certificates, reflecting a year-on-year increase of 4.5 times [19][20] - The urban renewal plan includes over 60,000 projects with an estimated investment of approximately 2.9 trillion yuan, focusing on the renovation of aging urban infrastructure [36][39] Investment Recommendations - The report recommends specific companies within various sectors, including Jiangsu Guoxin in the thermal power sector, and suggests cautious investment in companies like Sheneng Co. and Zhejiang Energy [5][24]

Market Performance - In April 2025, the average return of actively managed equity funds was -2.4%, indicating a convergence in investment strategies among fund managers in the current market environment [1][9]. - Value funds performed the best among non-sector equity funds, with a median return of -1.3%. Growth funds showed the greatest internal differentiation, with returns ranging from a maximum of 6.2% to a minimum of -12% [23][24]. - The average return of actively managed equity funds in the healthcare and consumer sectors was 2.8% and 0.5%, respectively, indicating strong performance in these areas [24][29]. - Passive funds in the technology and financial sectors maintained an advantage, with technology index products averaging a return of 27.8% and financial index products averaging 22.2% over the past year [30][31]. Equity Fund Multi-Strategy Overview - The overall strategy distribution of public equity funds is shifting towards a convergence between single and multi-strategy approaches, with an average R² value of 0.80 [37]. - The most tracked funds this month were those focused on thematic sectors, with 1,220 funds (30.24% of the sample) following thematic strategies, and 1,124 funds (27.86%) focused on growth strategies [42]. - The report identified three major trends in fund strategy changes: underweighting financial real estate, transitioning from A-share core assets to Hong Kong core assets, and market capitalization downshifting [43]. Performance of High-Rated Funds - High-rated funds demonstrated excellent overall performance and robust investment management capabilities, showing good alpha persistence in both short-term and long-term performance [56]. - The number of AAA-rated funds increased from 21 to 25, while AA+ rated funds rose from 42 to 49, indicating an overall improvement in fund ratings [51][52]. - Value funds had the highest proportion of high-rated funds, with an internal performance rate of 14.1%, while small-cap funds saw an increase in performance rate from 6.7% to 8.6% [52]. Emerging and Upgraded Funds - New funds, defined as those with high return potential and differentiated competitive advantages, totaled five this month, primarily referencing the CSI 500 index [65]. - Upgraded funds exhibited significant performance improvements and management optimization, with ten funds achieving higher ratings this month [66].

Investment Rating - The report upgrades the investment rating to "Buy" based on the company's strong market position and expected performance [5][20]. Core Views - The initial ruling of the "double anti-dumping" investigation by the US against China's pulp molding industry has been released, with the company facing a significant anti-dumping tax rate of 470.63% [3]. - The company is strategically shifting its production to Thailand to mitigate the impact of tariffs, with a projected 52% of its revenue coming from exports to the US in 2024 [4]. - The global market for pulp molding is expected to grow at a compound annual growth rate (CAGR) of 7.60% from 2023 to 2030, indicating a broad future market potential [5]. Financial Performance and Forecast - The company is projected to achieve net profits of 357 million, 421 million, and 485 million yuan for the years 2025, 2026, and 2027 respectively, reflecting year-on-year growth rates of 10%, 18%, and 15% [5][7]. - Revenue is expected to grow from 1,546 million yuan in 2024 to 3,216 million yuan in 2027, with a CAGR of approximately 24% [7]. - The earnings per share (EPS) is forecasted to increase from 3.17 yuan in 2025 to 4.74 yuan in 2027 [7]. Market Position and Strategy - The company is recognized as a leading player in the domestic pulp molding market, benefiting from scale, research and development capabilities, and a strong customer base [5]. - The establishment of production facilities in Thailand is aimed at enhancing market competitiveness and addressing the challenges posed by the US tariffs [4][5]. - The company is actively exploring market opportunities in Europe, the Middle East, South America, and Australia to diversify its revenue streams [5].

Investment Rating - The industry rating is "Outperform the Market," indicating that the overall return of the industry is expected to exceed the market benchmark index by more than 5% in the next 6 months [10]. Core Insights - The report highlights that AI is upgrading traditional businesses and creating a second growth engine for various companies [2]. - Companies like Xiaomi, Alibaba, Tencent, Bilibili, and Kuaishou are leveraging AI technologies to enhance their business models and drive growth [4]. Summary by Relevant Sections Xiaomi Group - Launched the open-source reasoning model Xiaomi MiMo with 7 billion parameters, excelling in mathematical reasoning and coding competitions [4]. - Integrated AI across its ecosystem, connecting mobile phones, smart cars, and IoT devices to optimize AI capabilities [4]. - Strengthened collaboration with Kingsoft Cloud through the release of the ninth-generation cloud server C9a, suitable for scientific computing tasks [4]. Alibaba - Released the new generation of open-source model family Qwen3, significantly reducing costs with a "mixed reasoning" architecture [4]. - Invested over 380 billion yuan in the next three years for cloud and AI hardware infrastructure [4]. - Reported continuous triple-digit year-on-year growth in AI revenue for six consecutive quarters [4]. Tencent - Restructured its AI departments to enhance focus on foundational AI technologies [4]. - Launched the AI assistant "Yuanbao" within the WeChat ecosystem, enhancing its value as an AI entry point [4]. Bilibili - Introduced AI data insights for the "618" shopping festival, improving efficiency in brand and merchant collaborations [4]. - Strengthened AIGC capabilities to assist brands in material matching and reduce advertising costs [4]. Kuaishou - Established the Keling AI division, which has generated over 100 million yuan in revenue since its commercialization [4]. - Utilized AI to transform marketing and operational processes, including AI-generated advertising materials [4].

Investment Rating - The industry investment rating is "Outperform the Market" [8] Core Viewpoints - The report highlights strong growth in the personal care e-commerce sector, particularly in April, with local brands rapidly gaining market share through platforms like Douyin [1][2] - The report emphasizes the resilience of various personal care categories, with significant year-on-year growth in sales across multiple platforms [2] Summary by Relevant Sections E-commerce Performance - In April, the GMV (Gross Merchandise Value) for sanitary napkins on Tmall increased by 22% year-on-year, with notable growth from local brands such as Naise Princess (+21%), Jieting (+60%), and Taotao Oxygen Cotton (+136%) [2] - Douyin saw a remarkable 62% year-on-year increase in sanitary napkin GMV, with local brands like Naise Princess (+377%) and Jieting (+52%) showing strong performance [2] Oral Care - The GMV for toothpaste on Tmall rose by 24% year-on-year, with local brands like Lengsuaning (+158%) and Yunnan Baiyao (+42%) outperforming foreign brands [2] - Douyin's toothpaste GMV increased by 78% year-on-year, with local brands leading the rankings [2] Diapers - The GMV for diapers and pull-ups on Tmall increased by 42% year-on-year, with leading brands such as Huggies (+62%) and Pampers (+118%) driving category growth [2] Tissue Products - The GMV for tissue products on Tmall rose by 22% year-on-year, with major brands like Vinda (+26%) and Heart to Heart (+46%) showing upward sales trends [2] Investment Recommendations - The report recommends continued investment in the personal care sector, highlighting the rapid growth of local brands and their expansion into various online and offline channels [2]